ARL1

ARL1

A gene on chromosome 12q23.2 that encodes a GTP-binding protein belonging to the ARL (ADP-ribosylation) factor-like family of proteins, which are structurally similar to ADP-ribosylation factors (ARFs), which activate cholera toxin ADP-ribosyltransferase activity, regulate intracellular vesicular membrane trafficking and stimulate a phospholipase D isoform.
References in periodicals archive ?
ARL1, a LOB-domain protein required for adventitious root formation in rice.
All cynomolgus monkey samples were normalized by ADP-ribosylation factor-like 1 (ARL1), M0RF4 family-associated protein 1 (MRFAP1), and ADP-ribosylation factor GTPase activating protein 2 (ARF-GAP2) [26].
The ARL1 is the average time the algorithm takes to alert when there are aberrations in the system.
The above method models the expected count at each time point with covariates and monitors the difference between the observed and expected count using CUSUM; however, to maximize ARL0 and minimize ARL1 (and thus maximize both sensitivity and specificity), we need to find the appropriate h and k for each disease selected in this study.
Now, by taking a shift in 25 preliminary samples of 20 rated color of boats by inspectors, the parameters "p" and "q" are determined by using a simulation programming with the goal of minimizing the ARL1 as 0.1, 0.2.
The gene, designated Adventitious rootless1 (ARL1), encodes a protein with a LATERAL ORGAN BOUNDARIES (LOB) domain.
SE z p-0 D.ln(busp) 0.4394877 0.0085786 51.23 0.000 cat 8.68e-07 0.000012 0.07 0.942 cst 0.0015319 0.0016221 0.94 0.345 arL1 0.8382046 0.5109495 1.64 0.101 arL2 0.0170225 0.4519416 0.04 0.970 maLl -0.8280828 0.5218845 -1.59 0.113 maL2 -0.1203292 0.5073313 -0.24 0.813 D.ln(busp) 0.1340466 0.0789613 1.70 0.090 hetcat 0.000816 0.0007054 1.16 0.247 hetcat -0.3673754 0.1639719 -2.24 0.025 earchL1 -0.0398744 0.0413473 -0.96 0.335 earchL2 0.0554082 0.0363861 1.52 0.128 earchaLl 0.6983358 0.057588 12.13 0.000 earchaL2 0.8875543 0.047151 18.82 0.000 egarchL1 -0.0305064 0.0193224 -1.58 0.114 egarchL2 0.9381737 0.0149055 62.94 0.000 LogL 516.61382 Table 3.
Z p-0 tci -0.0000327 .0000104 -3.16 0.002 opi .0002185 .0001097 1.99 0.046 crt .0093303 .0096151 0.97 0.332 fleet .0046969 .006889 0.68 0.495 cst -1.556678 2.856471 -0.54 0.586 arL1 -.0818781 .0874084 -0.94 0.349 arL2 .8449426 .0844727 10.00 0.000 maL1 .3953347 .0959368 4.12 0.000 maL2 -.1644294 .1216234 -1.35 0.176 maL3 .0225011 .1015424 -0.22 0.825 maL4 -.1701627 .1197236 -1.42 0.155 sigma .6212577 .1393909 4.46 0.000 Table 5 D2SLAD Amemiya (1982) Regression lnscrap Coef.
Losses, Locus and Name % Comment * 1p36 003 CDC2L1 (p58) 27 1p13.2 015 NRAS 27 Amp 1q tel 023 1QTEL10 27 Sub Tel 2q23 [right arrow] q37 033 TBR1 27 2q33.3 [right arrow] q34 036 ERBB4 (HER-4) 27 Oncogene 3p12 [right arrow] 3p13 048 D3S1274, ROBO1 20 LOH 3q26.3 052 PIK3CA 36 Amp 5q tel 077 5QTEL70 27 Sub Tel 8p22 103 CTSB 27 Amp 9p11.2 118 AFM137XA11 27 10p tel 127 SHGC-44253 20 Sub Tel 10p13 131 BMI1 27 10q23.3 134 PTEN 27 TSG 12q23 167 DRIM, ARL1 27 17p13.3 206 PAFAH1B1 (LIS1) 20 18q21.3 233 BCL2 3 30 Amp 19p tel 237 stSG42796 45 Sub Tel * Amp indicates cancer amplicon previously described in the literature Sub Tel, sub telomeric sequence; Oncogene, known oncogene; LOH, loss of heterozygosity; and TSG, tumor suppressor gene.